Forbes July 11, 2024
Topline
Pfizer on Thursday said it is moving forward with a once-daily weight loss pill, danuglipron, after getting promising data from an early-stage trial, a milestone for the pharma giant hoping to enter the lucrative obesity drug market and compete with popular weight loss injections Wegovy and Zepbound.
Key Facts
How Long Until Pfizer’s Weight Loss Pill Reaches The Market?
Danuglipron is still undergoing early-stage clinical trials and even in the best case scenario for the drugmaker it will still be many years before the pill reaches consumers. If the drug succeeds in mid-stage trials, which is far from guaranteed, Pfizer must then undertake late-stage trials, which can be lengthy and for which there are also no guarantees of success....
Today's Sponsors
Today's Sponsor